Contraceptive effectiveness, pharmacokinetics, and safety of Sayana® Press when injected every four months: a multicenter phase 3 trial

BACKGROUND: Sayana Press® is a 3-monthly contraceptive injection approved by regulatory agencies in more than 40 countries worldwide. Existing effectiveness and pharmacokinetics (PK) data suggest that high contraceptive efficacy may be maintained if the reinjection interval of Sayana Press is extend...

Descripción completa

Detalles Bibliográficos
Autores principales: Deese, Jennifer, Brache, Vivian, Bahamondes, Luis, Salinas, Abril, Jorge, Aidelis, Veiga, Nelio, Fuchs, Rachael, Miller, Ashley, Taylor, Doug, Halpern, Vera, Dorflinger, Laneta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804165/
https://www.ncbi.nlm.nih.gov/pubmed/35128365
http://dx.doi.org/10.1016/j.eclinm.2022.101273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804165/
https://www.ncbi.nlm.nih.gov/pubmed/35128365
http://dx.doi.org/10.1016/j.eclinm.2022.101273

Ejemplares similares